Results 201 to 210 of about 70,470 (286)

Prognostic value of NT-proBNP monitoring in patients with left ventricular assist devices. [PDF]

JHLT Open
Cherbi M, Verdaguer J, Itier R, Barde L, Fournier P, Grunenwald E, Gaudard P, Rouvière P, Molina A, Ughetto A, Delmas C.   +10 more
europepmc   +1 more source

Efficacy of SGLT2 Inhibitors on Clinical Outcomes After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta‐Analysis

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 2, March 2026.
SGLT2 inhibitor therapy was associated with a significantly lower risk of the composite outcome of all‐cause mortality or heart failure hospitalization at one year, as well as each component individually. ABSTRACT Background Sodium‐glucose cotransporter 2 (SGLT2) inhibitors improve cardiovascular (CV) outcomes in patients with heart failure (HF) and ...
Shaikh Muhammad Daniyal, Naveen Murad Khatoon, Anas Rasool, Isbah Gul, Sabula Tabish, Shireen Asifa, Ayan Khalid, Zunaira Aftab, Muhammad Burhan, Syeda Laiba Fahim, Habiba Tauqir Gondal, Muhammad Asfandyar Nadir, Syed Zaeem Ahmed, Danish Ali Ashraf, Somaiya Ahmed   +14 more
wiley   +1 more source

NT-proBNP testing for heart failure diagnosis in people with atrial fibrillation: A diagnostic accuracy study. [PDF]

PLoS Med
Jones NR, Taylor KS, Ordóñez-Mena JM, Goyder CR, Hobbs FDR, Taylor CJ.   +5 more
europepmc   +1 more source

Iron, arginine, and redox metabolism in peripheral blood mononuclear cells distinguishes sickle cell disease and pulmonary hypertension

HemaSphere, Volume 10, Issue 3, March 2026.
Abstract Pulmonary hypertension (PH) is a severe vascular complication of sickle cell disease (SCD); yet, not all patients with SCD develop PH, and PH also arises independently. This duality underscores the need to understand their intersecting biology.
Francesca I. Cendali, Christina Lisk, Amy Argabright, Monika Dzieciatkowska, Nishant K. Rana, Delaney Swindle, Daniel Stephenson, Julie McAfee, Natalie Westover, Melissa Lucero, Aneta Gandjeva, Kurt Stenmark, Rubin Tuder, Brian B. Graham, Tim Lahm, Vijaya Karoor, Gemlyn George, Kathryn Hassel, Rachelle Nuss, Pavel Davizon‐Castillio, Paul W. Buehler, Angelo D'Alessandro, David C. Irwin   +22 more
wiley   +1 more source

A Rapid Method Based on Colloidal Selenium Nanoparticle to Detect NT-proBNP Antigen in Serum for Monitoring Acute Heart Failure. [PDF]

Int J Nanomedicine
Tang C, Xiang H, Zhu J, Chen T, Shao J, Gu L, Shen Y, Zhu Y.   +7 more
europepmc   +1 more source

The Relationship Between Dietary Inflammatory Index and Intermediate‐to‐High‐Risk Cardiovascular‐Kidney‐Metabolic Syndrome and All‐Cause Mortality: The National Health and Nutrition Examination Survey 1999–2018: A Cross‐Sectional and Prospective Cohort Study

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background The dietary inflammatory index (DII) score quantifies the inflammatory potential of an individual's diet and may be associated with cardiovascular–kidney–metabolic syndrome (CKM) and mortality risk. However, evidence on the relationship between DII and intermediate‐to‐high‐risk cardiovascular–kidney–metabolic syndrome (IH–CKM) is ...
Honglin Li, Mu Lin, Yane Yang, Liyan Wang, Yao Wang, Jiayu Lu, Meiju Li, Yanfei Zhao, Sining Chen, Chenxuan Gao, Chuanwei Zhao   +10 more
wiley   +1 more source

NT-proBNP(用語解説)

Journal of JCS Cardiologists, 2009
openaire   +2 more sources

From Tumor Marker to Congestion Indicator: The Expanding Role of CA‐125 in Heart Failure and Beyond

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims To evaluate the transition of Carbohydrate antigen 125 (CA‐125) from an ovarian tumor marker to a versatile indicator of systemic congestion and fluid overload. Methods A literature review (1984–2025) was conducted using PubMed, Scopus, and Web of Science. Keywords included “CA‐125,” “systemic congestion,” and related terms.
Minoo Heidari Almasi, Seyed Amirhossein Salehi, Azin Ebrahimi, Ladan Heidaresfahani, Amirahmad Nassiri   +4 more
wiley   +1 more source

Association between troponin and NT-proBNP levels, cytokines, and clinical outcomes in early sepsis response: a cohort study. [PDF]

Braz J Anesthesiol
Nedel W, Portela LV.
europepmc   +1 more source

Therapeutic Efficacy and Safety Profile of Eplontersen in Hereditary Transthyretin‐Mediated Amyloidosis: A Systematic Review

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Hereditary transthyretin‐mediated amyloidosis (hATTR) is a disorder that affects several body systems and can result in life‐threatening conditions like cardiomyopathy and polyneuropathy. For treatment of hATTR in the new medical realm, there is a breakthrough discovery of a medicine called Eplontersen, which targets the underlying ...
Zeel Vishnubhai Patel, Verkha Kumari, Paras, Bethineedi Lakshmi Deepak, Priyadarshi Prajjwal, Kolanu Nikhil Deep, Rakhi Bai, Serene Sara John, Omniat Amir Hussin   +8 more
wiley   +1 more source